Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis.

ABSTRACT:

Goals and background

A panel of 9 experts in nonalcoholic steatohepatitis gathered to assess multiple components of the diagnostic process.

Materials and methods

The Clinical Assertion Statements covered screening of patients with type 2 diabetes for high-risk nonalcoholic fatty liver disease, which-if any-noninvasive tests could determine whether to delay or defer biopsy, whether primary care providers and endocrinologists should routinely calculate Fibrosis-4 (FIB-4) scores in patients with nonalcoholic fatty liver disease or those at risk for it, optimal noninvasive tests to stage fibrosis, the need to consider fibrosis in patients with normal transaminase levels, periodic monitoring for progressive fibrosis, whether patients should undergo biopsy before pharmacotherapy,

SUBMITTER: Jacobson IM 

PROVIDER: S-EPMC9911115 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature